PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Ad blockers may be showing users more problematic ads, NYU Tandon study finds

Privacy-conscious users relying on "acceptable ads" programs encounter 13.6% more problematic content than those without ad blockers, researchers discover

2025-07-09
(Press-News.org) Ad blockers, the digital shields that nearly one billion internet users deploy to protect themselves from intrusive advertising, may be inadvertently exposing their users to more problematic content, according to a new study from NYU Tandon School of Engineering.

The study, which analyzed over 1,200 advertisements across the United States and Germany, found that users of Adblock Plus's "Acceptable Ads" feature encountered 13.6% more problematic advertisements compared to users browsing without any ad blocking software. The finding challenges the widely held belief that such privacy tools uniformly improve the online experience.

"While programs like Acceptable Ads aim to balance user and advertiser interests by permitting less disruptive ads, their standards often fall short of addressing user concerns comprehensively," said Ritik Roongta, NYU Tandon Computer Science and Engineering (CSE) PhD student and lead author of the study that will be presented at the 25th Privacy Enhancing Technologies Symposium on July 15, 2025. Rachel Greenstadt, CSE professor and faculty member of the NYU Center for Cybersecurity, oversaw the research.

The research team developed an automated system using artificial intelligence to identify problematic advertisements at scale. To define what constitutes "problematic," the researchers created a comprehensive taxonomy drawing from advertising industry policies, regulatory guidelines, and user feedback studies.

Their framework identifies seven categories of concerning content: ads inappropriate for minors (such as alcohol or gambling promotions), offensive or explicit material, deceptive health or financial claims, manipulative design tactics like fake urgency timers, intrusive user experiences, fraudulent schemes, and political content without proper disclosure.

Their AI system, powered by OpenAI's GPT-4o-mini model, matched human experts' judgments 79% of the time when identifying problematic content across these categories.

The study revealed particularly concerning patterns for younger internet users. Nearly 10% of advertisements shown to underage users in the study violated regulations designed to protect minors. This highlights systematic failures in preventing inappropriate advertising from reaching children, the very problem that drives many users to adopt ad blockers in the first place.

Adblock Plus’s Acceptable Ads represents an attempt at compromise in the ongoing battle between advertisers and privacy advocates. The program, used by over 300 million people worldwide, works by maintaining curated lists of approved advertising exchanges (the automated platforms that connect advertisers with websites) and publishers (the websites and apps that display ads). The program allows certain advertisements to bypass ad blockers if they meet "non-intrusive" standards.

However, the NYU Tandon researchers discovered that advertising exchanges behave differently when serving ads to users with ad blockers enabled. While newly added exchanges in the Acceptable Ads program showed fewer problematic advertisements, existing approved exchanges that weren't blocked actually increased their delivery of problematic content to these privacy-conscious users.

"This differential treatment of ad blocker users by ad exchanges raises serious questions," Roongta noted. "Do ad exchanges detect the presence of these privacy-preserving extensions and intentionally target their users with problematic content?"

The implications extend beyond user experience. The researchers warn that this differential treatment could enable a new form of digital fingerprinting, where privacy-conscious users become identifiable precisely because of their attempts to protect themselves. This creates what the study calls a "hidden cost" for privacy-aware users.

The $740 billion digital advertising industry has been locked in an escalating arms race with privacy tools. Publishers lose an estimated $54 billion annually to ad blockers, leading nearly one-third of websites to deploy scripts that detect and respond to ad blocking software.

"The misleading nomenclature of terms like 'acceptable' or 'better' ads creates a perception of enhanced user experience, which is not fully realized," said Greenstadt.

This study extends earlier research by Greenstadt and Roongta, which found that popular privacy-enhancing browser extensions often fail to meet user expectations across key performance and compatibility metrics. The current work reveals another dimension of how privacy technologies may inadvertently harm the users they aim to protect.

In addition to Greenstadt and Roongta, the current paper's authors are Julia Jose, an NYU Tandon CSE PhD candidate, and Hussam Habib, research associate at Greenstadt’s PSAL lab.

END


ELSE PRESS RELEASES FROM THIS DATE:

Verbal response time reveals hidden sleepiness in older adults

2025-07-09
A new study led by UCLA investigators shows that Verbal Reaction Time (VRT), the amount of time it takes a person to respond verbally, can be a marker of sleepiness in older adults. The study, which measured participants’ voice data through standardized cognitive assessments, show how VRT can passively detect excessive sleepiness, especially among older individuals using sedative medications. Why it matters Sleepiness is a major contributor to safety risks in daily life, but is often underreported or unnoticed, especially among older ...

University of Maryland School of Medicine launches groundbreaking study on THC/CBD therapy for dementia-related agitation at end of life

2025-07-09
The University of Maryland School of Medicine (UMSOM) Palliative Medicine Program has launched a new clinical trial funded by the National Institute on Aging to explore a potential treatment for agitation in patients with dementia nearing the end of life. The study focuses on an investigational oral drug, T2:C100, which contains the two active ingredients in cannabis: THC and CBD. Currently, standard medications such as morphine, valium, and Haldol are commonly used to manage agitation in hospice-eligible patients with dementia. However, these treatments are often ineffective ...

Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery

2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.006 This new article publication from Acta Pharmaceutica Sinica B, discusses targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery.   Triple-negative breast cancer (TNBC) is aggressive, with high recurrence rates and poor prognosis. Paclitaxel (PTX) remains a key chemotherapeutic agent for TNBC, but its efficacy diminishes due to the emergence of drug resistance, largely driven by cancer stem-like cells (CSCs), vasculogenic mimicry (VM) formation and tumor immunosuppressive ...

SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts

2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.017 This new article publication from Acta Pharmaceutica Sinica B, discusses how SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts.   Idiopathic pulmonary fibrosis (IPF), a chronic interstitial lung disease, is characterized by aberrant wound healing, excessive scarring and the formation of myofibroblastic foci. Although the role of alternative splicing (AS) in the pathogenesis of organ fibrosis has garnered increasing attention, ...

Psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis

2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.001 This new article publication from Acta Pharmaceutica Sinica B, discusses how a psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis.   Ovarian tumor (OT) is the most lethal form of gynecologic malignancy, with minimal improvements in patient outcomes over the past several decades. Metastasis is the leading cause of ovarian cancer-related deaths, yet the underlying mechanisms remain poorly understood.   Psychological stress is known to activate ...

An anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 i

2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.008 This new article publication from Acta Pharmaceutica Sinica B, discusses how an anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 inflammasome activation.   The coinfection of respiratory viruses and bacteria is a major cause of morbidity and mortality worldwide, despite the development of vaccines and powerful antibiotics. As a macromolecule that is difficult to absorb in the gastrointestinal tract, a homogeneous polysaccharide from Houttuynia cordata (HCPM) has been reported ...

ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells

2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.018 This new article publication from Acta Pharmaceutica Sinica B, discusses how ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells.   Chemotherapy is currently the mainstay of systemic management for triple-negative breast cancer (TNBC), but chemoresistance significantly impacts patient outcomes.   This research indicates that Doxorubicin (Dox)-resistant TNBC cells exhibit increased glycolysis and ATP generation compared to their parental cells, with this metabolic shift contributing to chemoresistance. It was discovered ...

A photodynamic nanohybrid system reverses hypoxia and augment anti-primary and metastatic tumor efficacy of immunotherapy

2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.007 This new article publication from Acta Pharmaceutica Sinica B, discusses how a photodynamic nanohybrid system reverses hypoxia and augments anti-primary and metastatic tumor efficacy of immunotherapy.   Photodynamic immunotherapy is a promising strategy for cancer treatment. However, the dysfunctional tumor vasculature results in tumor hypoxia and the low efficiency of drug delivery, which in turn restricts the anticancer effect of photodynamic immunotherapy.   The ...

Acta Pharmaceutica Sinica B Volume 15, Issue 6 Publishes

2025-07-09
https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b/vol/15/issue/6 Acta Pharmaceutica Sinica B (APSB) was founded with the goal of creating a global high-level forum centred around drug discovery and pharmaceutical research/application. APSB was included by Chemical Abstracts in 2011, accepted by PubMed Central in 2015, indexed by Science Citation Index in 2017 and has evolved to become one of the most important international journals in the field of pharmaceutical sciences. APSB is a monthly journal, in English, which publishes ...

From injury to agony: Scientists discover brain pathway that turns pain into suffering

2025-07-09
LA JOLLA (July 9, 2025)—Pain isn’t just a physical sensation—it also carries emotional weight. That distress, anguish, and anxiety can turn a fleeting injury into long-term suffering. Researchers at the Salk Institute have now identified a brain circuit that gives physical pain its emotional tone, revealing a new potential target for treating chronic and affective pain conditions such as fibromyalgia, migraine, and post-traumatic stress disorder (PTSD). Published on July 9, 2025, in Proceedings of the National Academy of Sciences, the study identifies a group of neurons in a central brain area called the thalamus ...

LAST 30 PRESS RELEASES:

New electroenzymatic strategy enables non-natural oxidation reactions

Tunable laser light

Scientists uncover magnetic-field control of ultrafast spin dynamics in 2D ferromagnets

New AI-powered model accurately predicts lung motion with minimal radiation

AI language models show promise in predicting liver cancer treatment outcomes

Tracking insect and bug health in a heartbeat from a digital camera

'Talking fish' not heard by conservation policies, SFU study warns

Thirty years of research shows increased resistance in fungi

Junk food ‘avoids advertising regulation’ with top level UK sports sponsorship

Banking on AI while committed to net zero is ‘magical thinking’, claims report on energy costs of big tech

Ancient river systems reveal Mars was wetter than we thought

Online toolkit to help parents of autistic children improve dental health

The psychological and neurological parallels between sports fandom and religious devotion

Agricultural liming in the US is a large CO2 sink, say researchers

Seaside more likely to make us nostalgic than green places, study finds

Psilocybin delays aging, extends lifespan, Emory study suggests

Buck Institute awarded DARPA contract to pioneer next-gen AI modeling platform

Orange is the new aphrodisiac—for guppies

Murals boost Cincinnati’s vitality, community development

Ad blockers may be showing users more problematic ads, NYU Tandon study finds

Verbal response time reveals hidden sleepiness in older adults

University of Maryland School of Medicine launches groundbreaking study on THC/CBD therapy for dementia-related agitation at end of life

Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery

SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts

Psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis

An anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 i

ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells

A photodynamic nanohybrid system reverses hypoxia and augment anti-primary and metastatic tumor efficacy of immunotherapy

Acta Pharmaceutica Sinica B Volume 15, Issue 6 Publishes

From injury to agony: Scientists discover brain pathway that turns pain into suffering

[Press-News.org] Ad blockers may be showing users more problematic ads, NYU Tandon study finds
Privacy-conscious users relying on "acceptable ads" programs encounter 13.6% more problematic content than those without ad blockers, researchers discover